Delcath Systems Stock

Delcath Systems Net Margin

The Net Profit Margin of Delcath Systems (DCTH) as of Jul 25, 2026 is 3.17 %. In the previous year, Net Profit Margin was -70.92 % — a change of -104.47% (higher).

Net Margin

3.17 %

YoY

-104.47%

Last updated:

Net Profit Margin of Delcath Systems is 2026 3.17 % . Net Profit Margin of Delcath Systems was 2025 -70.92 % . It decreases by -104.47% higher compared to the previous year.

For Delcath Systems, the net margin of 3.2% is up versus -721.5% a few years ago.

Access this data via the Eulerpool API

Delcath Systems Stock analysis

What does Delcath Systems do? Delcath Systems Inc is a US-American medical technology company specializing in the development of innovative products for the treatment of various forms of liver cancer. The company was founded in 1988 in New York and is headquartered in Queensbury today. Delcath Systems is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Delcath Systems stock

Net Profit Margin of Delcath Systems is 3.17 % in 2026.

Access this data via the Eulerpool API

Margins — Delcath Systems

All Key Metrics — Delcath Systems